Metabolite List
all metabolites that has the same formula 'C19H26O2'
1-Methylestra-1,3,5(10)-triene-3,17beta-diol (BioCAD00000001396)
Formula: C19H26O2 (Exact Mass: 286.1933)
17beta-Hydroxyandrosta-4,9(11)-dien-3-one (BioCAD00000002138)
Formula: C19H26O2 (Exact Mass: 286.1933)
5-Androstene-3,17-dione (BioCAD00000004749)
Formula: C19H26O2 (Exact Mass: 286.1933)
androst-5-ene-3,17-dione, also known as delta5-ADD or δ5-add, is classified as an androgen or an Androgen derivative. Androgens are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. androst-5-ene-3,17-dione is considered to be practically insoluble (in water) and relatively neutral
Androstenedione (BioCAD00000006571)
Formula: C19H26O2 (Exact Mass: 286.1933)
Androstenedione is a delta-4 19-carbon steroid that is produced not only in the testis, but also in the ovary and the adrenal cortex. Depending on the tissue type, androstenedione can serve as a precursor to testosterone as well as estrone and estradiol. It is the common precursor of male and female sex hormones. Some androstenedione is also secreted into the plasma and may be converted in peripheral tissues to testosterone and estrogens. Androstenedione originates either from the conversion of dehydroepiandrosterone or from 17-hydroxyprogesterone. It is further converted to either testosterone or estrone. The production of adrenal androstenedione is governed by ACTH, while the production of gonadal androstenedione is under control by gonadotropins.
Boldenone (BioCAD00000007558)
Formula: C19H26O2 (Exact Mass: 286.1933)
Dehydrotestosterone
Cannabidivarin (BioCAD00000007920)
Formula: C19H26O2 (Exact Mass: 286.1933)
Cannabidivarin is a monoterpenoid. Cannabidivarin, also known as cannabidivarol or CBDV, is a non-psychoactive cannabinoid found within [DB14009]. It is one of over 100 cannabinoids identified from the Cannabis plant that can modulate the physiological activity of cannabis, or marijuana. Compared to its homolog, [DB09061], CBDV is shortened by two methyl (CH2) groups on its side chain. Notably, both [DB09061] and CBDV have demonstrated anticonvulsant activity in animal and human models and are demonstrating promising clinical trial results. Other cannabinoids with some evidence of anti-epileptic activity include [DB11755] (THCV) and Δ9-tetrahydrocannabinolic acid. While the primary components of cannabis, CBD and THC, have been shown to modulate many of their physiological effects through their binding to the cannabinoid-1 (CB1R) and cannabinoid-2 (CB2R) receptors, the investigational cannabinoids with anticonvulsant action mostly use mechanisms that do not involve these two endocannabinoid receptors. The anti-epileptic activity of CBD and CBDV is thought to be modulated by their effects on transient receptor potential cation channel subfamily V member 1 (TRPV1), also known as the capsaicin receptor, which is a member of a large family of ion channels that are involved in the onset and progression of several types of epilepsy. CBD and CBDV have been shown to dose-dependently activate and then desensitize TRPV1 as well as TRPV2 and TRPA1 channels. Desensitization of these ion channels is a potential mechanism by which these molecules cause a reduction of neuronal hyperexcitability that contributes to epileptic activity and seizures. CBDV has also been shown to inhibit the activity of diacylglycerol (DAG) lipase-α, the primary enzyme responsible for the synthesis of the endocannabinoid, 2-arachidonoylglycerol (2-AG). The clinical implications of this are unclear however, as this interaction has not been shown to affect CBDV's anticonvulsant activity. Cannabidivarin is being actively developed by GW Pharmaceuticals as the experimental compound GWP42006 as it has "shown the ability to treat seizures in pre-clinical models of epilepsy with significantly fewer side effects than currently approved anti-epileptic drugs". Unfortunately, as of February 2018, GW Pharmaceuticals announced that their Phase 2a placebo-controlled study of CBDV for focal seizure did not reach its primary endpoints. They will continue to study its use in epilepsy, however, and are expanding their investigations to include its potential use in Autism Spectrum Disorder, Rett syndrome and Fragile X among others. In October 2017 CBDV was given orphan designation by the European Medicines Agency for use in Rett Syndrome and again in February 2018 for treatment of Fragile X Syndrome. Cannabidivarin is a natural product found in Cannabis sativa with data available. See also: Cannabis sativa subsp. indica top (part of).
Citronellyl cinnamate (BioCAD00000035163)
Formula: C19H26O2 (Exact Mass: 286.1933)
Citronellyl cinnamate is used in food flavouring.
Tetrahydrocannabivarol (BioCAD00000175687)
Formula: C19H26O2 (Exact Mass: 286.1933)
Tetrahydrocannabivarol is a natural product found in Cannabis sativa with data available.
(8R,9R,10R,13S,14S)-10,13-Dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione (BioCAD00000177546)
Formula: C19H26O2 (Exact Mass: 286.1933)
Cannabidivarin (BioCAD00000178879)
Formula: C19H26O2 (Exact Mass: 286.1933)
1,3-Dimethoxy-5-methyl-2-(3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl)benzene (BioCAD00000183759)
Formula: C19H26O2 (Exact Mass: 286.1933)
(8R,9R,10R,13S,14S)-10,13-Dimethyl-5,6,7,8,9,11,12,14,15,16-decahydro-4H-cyclopenta[a]phenanthrene-3,17-dione (BioCAD00000185154)
Formula: C19H26O2 (Exact Mass: 286.1933)
5-androstene-3,17-dione (BioCAD00000230787)
Formula: C19H26O2 (Exact Mass: 286.1933)
5-androstene-3,17-dione belongs to androgens and derivatives class of compounds. Those are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. 5-androstene-3,17-dione is practically insoluble (in water) and an extremely weak acidic compound (based on its pKa). 5-androstene-3,17-dione can be found in a number of food items such as taro, red raspberry, calabash, and garland chrysanthemum, which makes 5-androstene-3,17-dione a potential biomarker for the consumption of these food products.
15:6(2Z,4E,6Z,8E,12E,14)(6Me,8Me,10Me[S],13Me) (BioCAD00000425438)
Formula: C19H26O2 (Exact Mass: 286.1933)
15:6(2Z,4E,6Z,8E,12E,14)(6Me,8Me,10Me[S],13Me)